Verenium Corp

Sequenom provides genetic analysis products that translate genomic science into solutions for non-invasive prenatal testing, biomedical research, molecular medicine and agricultural applications. Its proprietary MassARRAY system is a DNA analysis platform that measures the amount of genetic target material and variations therein. The system is able to deliver specific data from biological samples and from trace amounts of genetic target material. The company has licensed intellectual property rights for the development and commercialization of non-invasive prenatal genetic tests for use with the MassARRAY system and other platforms. Sequenom has headquarters in San Diego and offices in Newton, Mass, Germany, England and Australia.

Zenobia Therapeutics Inc is a San Diego-based company specializing in fragment-based lead discovery for the development of treatments for neurodegenerative diseases. With a focus on the central nervous system (CNS), their products and services have successfully yielded hits for a diverse range of targets worldwide. Founded in 2008, Zenobia Therapeutics expanded in 2014 to include Zenobia Fragments, a division dedicated to supplying highly core diverse fragments and unique reagents for protein solubilization and crystallization. Complementing their product offerings, Zenobia also provides screening and structural biology services to support fragment library purchases, solidifying their position as a leader in fragment-based lead discovery and CNS disease research.Generated from the website